The Latest Cardiac and Vascular News
Targets one of Healthcare’s Largest Multi-Billion Dollar Markets: Cardiac Electrophysiology TAMPA, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) — H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that it has entered into a letter of intent for the acquisition of Catheter Precision, Inc. Catheter Precision is a medical device […]
American Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient response to SGLT2 therapy in 1,325 CANagliflozin CardioVAScular Assessment Study (CANVAS) multinational clinical trial cohort patients NEW YORK and SALT LAKE CITY, Jan. 11, 2022 (GLOBE NEWSWIRE) — Renalytix (NASDAQ: RNLX) (LSE: RENX) announced the publication of positive study results for […]
– Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S. Net Product Revenue Estimated Between $12.0 to $12.5 Million – – Company Reiterates Full-Year 2022 Operating Expense Guidance of $220 to […]
New code establishes a reimbursement pathway for use of Nanox.AI’s HealthCCSng, designed to promote increased detection of risks for cardiovascular disease in the U.S. population and broader adoption of AI in radiology and population health Achievement follows company’s industry-first code for utilizing AI in imaging with AI detection of vertebral compression […]
Receipt of dedicated CPT® codes mark important commercialization milestone to pursue reimbursement for Prevencio’s multi-protein HART CADhs®, HART CVE®, and HART KD® Blood Tests KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., The AI-driven Cardiac Company™, today announces that the American Medical Association (AMA) has assigned three new, dedicated Current Procedural Terminology (CPT®) Proprietary Laboratory Analysis […]
Minimally invasive procedure decreases recovery time and demonstrates new opportunities in outpatient care LEOMINSTER, Mass.–(BUSINESS WIRE)–The Vascular Care Group (TVCG), a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, today announced Stephen J. Hoenig M.D. successfully completed a percutaneous femoral-popliteal artery bypass at the Leominster, Mass. […]
First Medtronic TAVR system approved in China for patients with symptomatic severe aortic stenosis DUBLIN, Jan. 10, 2022 /PRNewswire(opens new window)/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the National Medical Products Administration (NMPA) has approved the CoreValve™ Evolut™ PRO TAVR system for the treatment of severe aortic stenosis (AS) […]
DiNAQOR retains option rights to own the co-developed capsids for the fields of cardiovascular and kidney disease ZURICH-SCHLIEREN, Switzerland and WESTMEAD, NSW, Australia, Jan. 10, 2022 /PRNewswire/ — DiNAQOR, a genetic medicine platform company focused on addressing severe inherited cardiac diseases, today announced it has entered into a research collaboration with Children’s Medical Research Institute (CMRI) in Australia to develop […]
Calon Cardio-Technology Ltd. and Leviticus-Cardio Ltd. announce the joint Development and Testing of a Wireless, Fully Implantable, Long-Term Blood Pump. SWANSEA, Wales and TEL AVIV, Israel, Jan. 10, 2022 /PRNewswire/ — Severe heart failure is the most life-threatening medical condition in all age groups across the globe. Implantable heart pumps, known as Ventricular Assist […]
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today provided a business update, including preliminary unaudited full-year 2021 revenue results. Amarin plans to discuss these results and expectations with investors in connection with the 40th Annual J.P. Morgan Healthcare Conference at which Amarin is […]
